Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Clinical Neurology,Pharmacology
Reference66 articles.
1. Barnett, R. Schizophrenia. Lancet 2018;391:648.
2. Peng, S., Li, W., Lv, L., Zhang, Z., and Zhan, X. BDNF as a biomarker in diagnosis and evaluation of treatment for schizophrenia and depression. Discov Med 2018;26:127-136.
3. Lieberman, J.A., Stroup, T.S., McEvoy, J.P., Swartz, M.S., Rosenheck, R.A., Perkins, D.O., et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-1223.
4. Orlovska-Waast, S., Kohler-Forsberg, O., Brix, S.W., Nordentoft, M., Kondziella, D., Krogh, J., et al. Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis. Mol Psychiatry 2019;24:869-887.
5. Lohr, J.B. and Browning, J.A. Free radical involvement in neuropsychiatric illnesses. Psychopharmacol Bull 1995;31:159-165.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献